Get a Roundup of Psychedelic News Stories in Your Inbox.

[contact-form-7 id="44" title="Newsletter Subscription Form"]

By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.

How does Time of Day Influence LSD Microdosing? New Study Hopes to Find Out

How does Time of Day Influence LSD Microdosing? New MindMed Study Hopes to Find Out

"Our goal is to provide insight on key parameters that may impact and explain the mechanisms behind low-dose treatments," says MindMed Executive President Dr. Miri Halperin Wernli.
Largest Psilocybin Therapy Trial Ever Conducted Shows Depressive Symptoms Rapidly ReduceShutterstock.com

Largest Psilocybin Therapy Trial Ever Conducted Shows Depressive Symptoms Rapidly Reduce

,
“A single dose of psilocybin generated a rapid response that lasted up to 12 weeks,” explains principal investigator Dr. David J. Hellerstein, who was evaluating Compass Pathways' novel drug formulation COMP360.
Why We're Excited About Compass Pathways New Clinical Trial Treating PTSD With PsilocybinShutterstock.com

Why We’re Excited About Compass Pathways’ New Clinical Trial Treating PTSD with Psilocybin

,
Compass Pathways (Nasdaq: CMPS) has announced the launch of a brand new psychedelic clinical trial, using psilocybin (the active ingredient in magic mushrooms) to treat PTSD, and there are multiple reasons to be excited about it. The Phase-2…

Can Psychedelics Cure Chronic Pain? This Promising Study Lays Groundwork for Future Clinical Trials

Nine out of the 11 chronic pain sufferers interviewed say they experienced some kind of lasting pain reduction while self-medicating with psychedelics.
PharmaTher Believes Ketamine Could Treat This Rare Neurological ConditionShutterstock.com

PharmaTher Believes Ketamine Could Treat This Rare Neurological Condition

,
The company is also exploring if ketamine can treat other neurological conditions, including Parkinson’s Disease, ALS, and CRPS.
New Evidence Microdosing Psychedelics Reduces Anxiety and DepressionShutterstock.com

New Evidence Microdosing Psychedelics Reduces Anxiety and Depression

This study also showed microdosers were less likely to use alcohol and were most likely to abstain from consuming alcohol entirely.
How Dr. Monnica Williams Launched the First-Ever Psychedelics Master’s Program: 'Nobody Took Me Seriously'

How Dr. Monnica Williams Created Canada’s First Psychedelic Master’s Degree Program: ‘Nobody Took Me Seriously’

After two long years of preparing documents and presenting to various committees, the program is in its final stages, and the University of Ottawa will soon begin accepting applications for the fall semester.
Jada Pinkett Smith Tackles Exclusion of People of Color From Psychedelic Research on 'Red Table Talk'Facebook Watch / Shutterstock.com

Jada Pinkett Smith Tackles Exclusion of People of Color From Psychedelic Research on ‘Red Table Talk’

“We know nothing scientific about psychedelics and people of color and how appropriate our treatments are for people in those communities," says psychedelic researcher Dr. Monnica Wiliams.
Shutterstock.com

American Overdose Deaths Reach Record High During COVID Pandemic—And New Study Shows Psychedelics Can Help

“After adjusting for a range of potential confounders, psychedelic use remained independently associated with a significantly reduced odds of subsequent daily opioid use,” researchers say.
How does Time of Day Influence LSD Microdosing? New Study Hopes to Find Out

How does Time of Day Influence LSD Microdosing? New MindMed Study Hopes to Find Out

"Our goal is to provide insight on key parameters that may impact and explain the mechanisms behind low-dose treatments," says MindMed Executive President Dr. Miri Halperin Wernli.
Largest Psilocybin Therapy Trial Ever Conducted Shows Depressive Symptoms Rapidly ReduceShutterstock.com

Largest Psilocybin Therapy Trial Ever Conducted Shows Depressive Symptoms Rapidly Reduce

,
“A single dose of psilocybin generated a rapid response that lasted up to 12 weeks,” explains principal investigator Dr. David J. Hellerstein, who was evaluating Compass Pathways' novel drug formulation COMP360.
Why We're Excited About Compass Pathways New Clinical Trial Treating PTSD With PsilocybinShutterstock.com

Why We’re Excited About Compass Pathways’ New Clinical Trial Treating PTSD with Psilocybin

,
Compass Pathways (Nasdaq: CMPS) has announced the launch of a brand new psychedelic clinical trial, using psilocybin (the active ingredient in magic mushrooms) to treat PTSD, and there are multiple reasons to be excited about it. The Phase-2…
Parents Are Open to Ketamine Therapy for Kids, Study FindsShutterstock.com

Parents Are Very Open to Ketamine Therapy for Kids, Study Finds

“As parents maintain decision-making capacity of their child’s medical care, parental consent is a key factor in the adoption of new treatments for adolescents," study authors explain.
Psychedelic Users Experienced Less Psychological Stress During COVID-19, Study FindsModvector / Shutterstock.com

Psychedelic Users Experienced Less Psychological Stress During COVID-19 Lockdowns, Study Finds

Researchers found stress further reduced for the participants that use psychedelic drugs at least once every six months.
FDA Authorizes Device to Quantify Psychedelics’ Effects on the BrainShutterstock.com

FDA Authorizes Cybin Device to Quantify Psychedelics’ Effects on the Brain

"This study of ketamine’s psychedelic effects while wearing headgear equipped with sensors to record brain activity could open up new frontiers of understanding," says Cybin's chief clinical officer.
Psychedelics Help Heal Childhood Trauma, Study FindsFGC / Shutterstock.com

Psychedelics Help Heal Childhood Trauma, Study Finds

Researchers find that there were significantly lower levels of complex trauma symptoms and feelings of internalized shame in study participants that had used psychedelics therapeutically.

Psilocybin Study for Tobacco Addiction Receives First Federal Psychedelics Research Grant in 50 Years

A Johns Hopkins Medicine professor says "it was only a matter of time," while lead researcher calls the historic grant "monumental" for the psychedelics movement.
Return Health Believes Psychedelics Can Treat Dementia

This New Company Believes Psychedelics Can Treat Dementia

There is currently no known cure for dementia, but Return Health CEO Dr. James Kuo says psychedelics offer "unprecedented" potential.
Psychedelic Use Associated with Reduced Risk of Heart Disease and Diabetes

Psychedelic Use Associated with Reduced Risk of Heart Disease and Diabetes

Researchers say there are several ways classic psychedelics could, directly and indirectly, lead to improved cardiometabolic health.
How Mindset Pharma Is Making and Defining 'Next-Generation Psychedelic Drugs'

How Mindset Pharma Is Making and Defining ‘Next-Generation Psychedelic Drugs’

CEO James Lanthier compares psychedelic medicines to aspirin, and explains why the company's lead candidate may be better than psilocybin.
World Boxing Association Partners with Psychedelics Company to Improve Brain Injury Treatment for Athletes

World Boxing Association Partners with Psychedelics Company for TBI and PTSD Research

"We believe in the promise of the resurgence of psychedelic medicine and are proud to be collaborating with Lobe Sciences as we work together to improve the lives and health of members of the WBA family," says WBA president Gilberto Jesús Mendoza.
86% of Oregon Adults Considering Psilocybin Are Interested in Microdosing

Vast Majority of Oregon Adults Interested in Psilocybin Want to Try Microdosing

On the flip side, 37% of Oregon adults surveyed said they did not know what psilocybin was.
Survey Shows American Psychologists Still Don't Really Understand Psychedelics

Survey Shows American Psychologists Still Don’t Really Understand Psychedelics

Less than half of psychologists surveyed agreed that psychedelics showed promise in the treatment of serious mental health issues.

Psyched Wellness to Study Amanita Muscaria Mushroom Extract for Sleep Disorders

Psychoactive compound muscimol has been shown to treat stress and anxiety, ease muscular pain, and promote restorative sleep.
Tim Ferriss and Michael Pollan Team Up to Launch UC Berkeley Psychedelic Journalism Fellowship

Tim Ferriss and Michael Pollan Team Up to Launch UC Berkeley Psychedelic Journalism Fellowship

Podcaster and author of "The 4-Hour Work Week" will gift the university's Center for the Science of Psychedelics $800,000 over 3 years to fund fellowship overseen by Professor Pollan.
UW-Madison Study Aims to Increase Minority Representation in Psychedelic Clinical Trials

UW-Madison Study Aims to Increase Minority Representation in Psychedelic Clinical Trials

"Certain demographic groups have been the recipients of more legal scrutiny related to substance use than the majority of the population,” says lead researcher Cody Wenthur.
4 Ways Psychedelics Can Positively Transform Women's Mental Health

4 Ways Psychedelics Can Positively Transform Women’s Mental Health

Jessika Lagarde, the co-founder of Women on Psychedelics, explores how various psychoactive substances can treat mental health issues including depression, eating disorders, PTSD, and addiction.

Algernon Pharmaceuticals Shows DMT Can Increase Neuron Growth by 40%

The Vancouver-based drug development company is investigating the use of DMT as a possible treatment for stroke.
Mindset Pharma's DMT-Inspired Drug Candidates Could Address Serotonin Syndrome Challenge

Mindset Pharma’s DMT-Inspired Drug Candidates Could Address Serotonin Syndrome Challenge

,
“The data suggests that we have a new drug that may be at least as effective, if not more effective, than 5-MeO-DMT and, more importantly, it looks like it is much safer," says Mindset Pharma CEO James Lanthier.
Scientists Begin Exploring Therapeutic Potential of Psilocybin Mushrooms Native to Australia

Scientists Begin Exploring Therapeutic Potential of Psilocybin Mushrooms Native to Australia

“Australian native ‘magic mushrooms’ may have evolved different methods for psilocybin production and offer adaptations that are preferential for use in clinical treatments," explains University of Queensland mycologist Dr. Alistair McTaggart.
University of Wisconsin-Madison Launches New Psychedelic Research Center

University of Wisconsin-Madison Launches New Psychedelic Research Center

This school offers the first accredited American degree focused on the study and therapeutic development of psychedelic compounds and related psychoactive drugs.
Psychedelics May Decrease Racial Trauma Symptoms Among People of Color

Psychedelics May Decrease Racial Trauma Symptoms Among People of Color

Study authors write, "Results showed significant and large reductions in the intensity of traumatic stress, depression, and anxiety symptoms from the 30 days before to the 30 days after a referent psychedelic experience."
Johns Hopkins and Mydecine Partner to Further Psychedelic Therapy for Smoking Addiction

Johns Hopkins and Mydecine Partner to Further Psychedelic Therapy for Smoking Addiction

“Cigarette smoking remains one of the most difficult addictions to treat and contributes to more deaths than all the other substances combined, making this research vital," says Mydecine Innovations Chief Medical Officer Dr. Rakesh Jetly.
Does Ayahuasca Change Personality Like Other Psychedelics? Study Says No

New Study Explores If Ayahuasca Changes Personality Like Other Psychedelics

Recent ayahuasca study concludes mixed messages in attempt to determine if the ancient plant medicine has power to change personality, as psilocybin has shown.
Reishi Mushrooms to treat breast cancer

Revive Therapeutics Is Exploring This Mushroom’s Potential to Treat Aggressive Breast Cancer

,
The company is also pursuing psilocybin as a possible treatment for rare cancers, but they see huge potential in researching the medicinal effects of the reishi mushroom.
Canada Green Lights Country’s Third Clinical Psilocybin Study

Canada Green Lights Country’s Third Clinical Psilocybin Study

The trial will build on Diamond Therapeutic's previous animal research that demonstrated how non-hallucinogenic doses of psilocybin hold the potential to treat psychiatric disorders, including anxiety and depression.
Beckley Psytech Raises $80 Million to Fund Psychedelic Research Pipeline

Beckley Psytech Raises $80 Million to Fund Psychedelic Research Pipeline

,
The company will use proceeds of the fundraising round to complete its ongoing Phase 1B trial on low-dose psilocybin in patients suffering from a rare headache condition with no approved medications to treat it.
First Neuroimaging Study of Psilocybin Microdosing Underway in Sydney

First Neuroimaging Study of Psilocybin Microdosing Underway in Sydney

Researchers hope to establish whether the effects of microdosing are as profound as people say they are, since previous studies could not rule out placebo effect.
What Is Salvia Divinorum and How Can the Psychedelic Help Humanity?

What Is Salvia Divinorum and How Can the Psychedelic Help Humanity?

Take a deep dive into the history, effects, and benefits of this psychoactive plant that is still largely under the radar as interest in psychedelics explodes.
Nova Mentis Reaches Milestone Developing Psilocybin to Treat Autism

Nova Mentis Reaches Milestone Developing Psilocybin to Treat Autism

,
Nova Mentis says that psilocybin could be a novel, first-in-class treatment for a brain disorder that leads to learning disabilities and behavioral problems.
Wesana Health Launches Animal Studies for Psilocybin and TBI

Wesana Health Launches Animal Studies for Psilocybin and TBI

,
According to the CDC, about 166 Americans die from TBI-related conditions each day.
5 Ways Psychedelics Can Help Humanity

5 Ways Psychedelics Can Help Humanity with Medicinal Benefits You Never Imagined

DMT treating eye disease? Psilocybin reducing obesity? The benefits of psychedelics could be truly far out as research continues to find novel applications.
Contract Research Organizations Partner to Accelerate European Psychedelic Clinical Trials

Contract Research Organizations Partner to Accelerate European Psychedelic Clinical Trials

A partnership between Clerkenwell Health and Transpharmation provides drug developers a one-stop-shop for all stages of psychedelic research.
Can a Compound in ‘Magic’ Mushrooms Cure Social Anxiety

Surveys Show: America’s Public Approval of Psychedelic Therapy Lags Behind Canada

,
We compare two polls of roughly the same sample size in two neighboring countries, and find a stark difference in attitudes.
Australia’s First Psychedelic Research Institute Psychae Opens with $40 Million Investment

Australia’s First Psychedelic Research Institute Opens with $40 Million Investment

Psychae Institute will collaborate with other clinical research organizations to develop novel psychedelic medicines and accompanying psychotherapeutic treatment models.
How the Heroic Hearts Project Is Spearheading Psilocybin Research to Treat Veterans for TBI

How the Heroic Hearts Project Is Spearheading Psilocybin Research to Treat Veterans for TBI

Dr. Grace Blest-Hopley tells Psychedelic Spotlight that the compound has anti-inflammatory effects on the brain, and explains how her team will investigate further through psilocybin retreats for veterans.
Oregon Psilocybin Advisory Board Finds the Psychedelic Reduces Depression and Anxiety

Oregon Psilocybin Advisory Board Finds the Psychedelic Reduces Depression and Anxiety

The subcommittee’s review is the largest of its kind to be conducted in the state, which legalized psilocybin for therapeutic and medicinal purposes last November.
Ayahuasca May Help Curb Drug and Alcohol Addiction

Ayahuasca May Help Curb Drug and Alcohol Addiction

New study compiles the experiences of 8,629 ayahuasca users from 40 different countries, and results are very promising for the future of psychedelic-assisted therapy.
How a Psilocybin Study on AIDS Survivors Could Solve a Big Problem with Psychedelic Therapy

How a Psilocybin Study on AIDS Survivors Could Solve a Big Problem with Psychedelic Therapy

,
A group psilocybin study paves the way for increased scalability of novel treatments that typically require a lot of time for both the patient and therapist.
Wake Network Developing Genetics-Based Screening System to Offer Patients Personalized Psychedelic Therapies

Wake Network Partners with Lieber Institute to Develop Genetics-Based Screening System for Psychedelic Therapies

, ,
Fungi bioscience company describes the project as “one of the most robust genetics research initiatives in the emerging psychedelics space to date."
Traumatic Brain Injury (TBI) psychedelic treatment daniel carcillo

How Wesana Health CEO Daniel Carcillo Plans to Protect Athletes From Traumatic Brain Injury

,
And why the two-time Stanley Cup champion does not imagine working with the NHL in the "near future."
COVID-19 Pandemic Study of Ketamine Amplifies Antidepressant Potential

COVID-19 Pandemic Study of Ketamine Therapy Amplifies Antidepressant Potential

,
Study authors even believe "treating serious mental illness may reduce adverse outcomes related to COVID-19."
Awakn Life Science CEO Anthony Tennyson "Groundbreaking" MDMA discovery

Awakn Life Sciences CEO Details ‘Groundbreaking’ MDMA Discovery in Quest to Treat Addiction

, ,
Anthony Tennyson tells the Psychedelic Spotlight Podcast that his company has "discovered receptor sites that MDMA interacts with that we believe nobody else in the world knows about."
Wesana Health to Acquire Psytech

Wesana Health to Acquire Psychedelic Therapy and Software Company PsyTech

, ,
The deal creates Wesana Clinics, a chain of mental health facilities focused on delivering psychedelic-assisted psychiatric care, as well as data platform Wesana Solutions.
Psychedelics asthma treatment

Why Psychedelics Could Eventually Treat Asthma

,
Researchers continue to explore anti-inflammatory nature of psychedelics, which in small doses, may alleviate asthma symptoms.
Microdosing cancer patients LSD study

New Zealand Psychologist Assembles First Study Microdosing Cancer Patients with LSD

University of Auckland researcher hopes the psychedelic treatment will enhance the effect of psychotherapy, easing end-of-life distress in patients.
Psychedelic clinical trials looking for volunteers

Want to Try Psychedelics in a Clinical Setting? 56 Trials Now Recruiting Volunteers

,
Here's how to become a research subject for psilocybin, LSD, MDMA, ibogaine, and 5-MeO-DMT studies.
Psilocybin depression treatment

Psychedelic Biotech Company Cybin Partners with Greenbrook to Develop Innovative Depression Treatment

, ,
Cybin CEO says agreement "serves as a major step toward establishing a national distribution network for future psychedelic therapies."

Single Dose of Psilocybin Strengthens Brain Connections in Mice, According to Yale Study

“It was a real surprise to see such enduring changes from just one dose of psilocybin," says senior study author Alex Kwan.
Psychedelics Domestic Violence

Can Psychedelics Reduce Domestic Violence? New Study Suggests Yes

Alcohol, methamphetamine and cocaine have been linked to increased aggression in men, but psychedelics appear to have opposite effect.

Harvard Law Launches Psychedelics Regulation Research Project

,
POPLAR is the first academic initiative focused on psychedelics law and policy.
Predicting Psychedelic Experience Outcomes Through Machine Learning

Predicting Psychedelic Experience Outcomes Through Machine Learning

New technology that employs machine learning is helping researchers predict psychedelic experience outcomes.
The Benefits of Peyote: Ancient Wisdom, Modern Medicine

‘Meaningful’ Mescaline Experience Linked to Improvements in Depression, Anxiety

Significant personal experiences on the psychedelic mescaline show great promise in treating anxiety and depression, new research finds.
Queen’s University Launches Psychedelic Research Collaborative

Queen’s University Launches Psychedelic Research Collaborative

Ontario’s Queen’s University’s is launching a psychedelics research collaborative to serve as a space for innovation, and education.
UNLV Researchers Discover a Brainwave Signature That Responds to Psychedelic Medicine

UNLV Researchers Discover a Brainwave Signature That Responds to Psychedelic Medicine

A research team from the University of Nevada at Las Vegas have discovered a brainwave signature that responds to psychedelic treatments.
Wesana Health and University of South Carolina Partner on Psychedelic Brain Research

Wesana Health and University of South Carolina Partner on Psychedelic Research for Brain Injuries

Psychedelic life sciences company Wesana Health has partnered with the University of South Carolina to study brain health.
Imperial College and Heroic Hearts Launch Psychedelic Research Retreat for Veterans with Head Trauma

Imperial College and Heroic Hearts Launch Psychedelic Research Retreat for Veterans with Head Trauma

,
A new veterans research-focused psychedelic retreat in partnership between Heroic Hearts and Imperial College looks at treating brain injuries.
Psychedelic Educational Platform Launches Integration Therapy Survey Study to Promote Harm Reduction

Psychedelic Educational Platform Launches Integration Therapy Survey Study to Promote Harm Reduction

,
A new platform is aimed at psychedelic experience integration and harm reduction by surveying practitioners and patients.
The University of Alabama Joins League of Research Facilities Granted Approval to Study Psychedelics

The University of Alabama Joins League of Research Facilities Granted Approval to Study Psychedelics

The University of Alabama at Birmingham is the latest to announce it will begin research into psychedelics.
How The Multidisciplinary Association for Psychedelic Studies Is Changing Mental Health Treatment

How The Multidisciplinary Association for Psychedelic Studies Is Changing Mental Health Treatment

The Multidisciplinary Association for Psychedelic Studies has been studying mental health treatment for more than 35 years. Here's what to know.

Texas Governor Signs Bill to Test Psychedelics As PTSD Treatment for Veterans

,
Texas Gov. Greg Abbott signed a bill requiring the state to study the risks and benefits of psychedelics for veterans suffering with PTSD.
Bringing Next-Gen Depression Treatment to Market: PharmaTher's Ketamine Patch

Bringing Next-Gen Depression Treatment to Market: PharmaTher’s Ketamine Patch

Psychedelic biotech company PharmaTher says its ketamine patch could help relieve depression better than other treatments.
40 'New' Psychedelic Compounds Found In More Than 25 Species of Mushrooms

40 ‘New’ Psychedelic Compounds Found In More Than 25 Species of Mushrooms

Mydecine Innovations Group says it has found 40 new compounds in at least 25 types of mushrooms with psychedelic and potentially therapeutic properties.
Study Finds Synthetic Psilocybin Did Not Adversely Affect Cognitive Function

Study Finds Synthetic Psilocybin Did Not Adversely Affect Cognitive Function

Is synthetic psilocybin as effective as the real thing? A new study looks at the risks and benefits of taking this lab-made psychedelic.
University of Calgary Creates Canada’s First Chair for Psychedelic Research

University of Calgary Creates Canada’s First Chair for Psychedelic Research

Canada gets its first chair for psychedelic research thanks to private citizen funding to the University of Calgary.
Psilocybin May Treat Phantom Limb Syndrome

80 to 100% of Amputees Experience Phantom Limb Syndrome. Psilocybin May Help.

New research into psychedelics shows psilocybin may help amputees suffering from pain associated with phantom limb syndrome.
Do Psychedelics Hold the Key to Explaining Near-Death Experiences?

Do Psychedelics Hold the Key to Explaining Near-Death Experiences?

New research into psychedelics shows it may help scientists better understand the phenomenon known as near-death experiences.
First Clinical Trial to Treat Frontline Workers Experiencing COVID-Related Distress

Cybin Launches First Clinical Trial to Treat Frontline Workers Experiencing COVID-Related Distress With Psychedelics

A new first-of-its-kind psychedelic study will treat frontline workers experiencing distress related to COVID with psilocybin.
Biotech Firm PsyBio Therapeutics Is Producing Psilocybin From Bacteria

Biotech Firm PsyBio Therapeutics Is Producing Psilocybin From Bacteria

PsyBio Therapeutics is harvesting the psychedelic compound psilocybin from a strain of bacteria instead of mushrooms.
Cybin Taps First-of-Its-Kind Device to Study Psychedelic Effects of Ketamine

Cybin Taps First-of-Its-Kind Device to Study Psychedelic Effects of Ketamine

A new device may help Cybin better understand the psychedelic impact of the drug ketamine on the human brain.
Research Looks at Psychedelics for Autism Treatment

Research to Look at Psychedelics for Autism Treatment

New research from Nova Mentis will explore the potential benefits of psychedelics in treating autism spectrum disorders.
FDA Approves First-Ever MDMA Study for Therapist Volunteers to Better Treat PTSD Patients

FDA Approves First-Ever MDMA Study for Therapist Volunteers to Better Treat PTSD Patients

The FDA has approved a novel study allowing therapists who treat PTSD to take MDMA to better understand the treatment benefits.
UNLV Researchers Discover a Brainwave Signature That Responds to Psychedelic Medicine

Algernon to Become the First Company in the World to Study DMT for Stroke Patients

Algernon Pharmaceuticals has received FDA approval to study DMT for use in stroke patients to help rebuild synaptic connections.
FDA Greenlights Ketamine for Parkinson's Disease Treatment

FDA Green-Lights Ketamine Study for Side Effects of Parkinson’s Disease Treatment

Research into ketamine as a potential treatment for Parkinson's patients suffering from drug side effects is getting FDA approval.
Can Psychedelics Cure Color Blindness

Could Psychedelics Cure Color Blindness? New Data Sees a Bright Future

Could psychedelics help people suffering from color blindness? New research sees great potential with lsd and psilocybin.
The World Boxing Council is the First Global Sports Governing Body to Research Psychedelic Treatment for Brain Injuries

The World Boxing Council Is the First Global Sports Governing Body to Research Psychedelic Treatment for Brain Injuries

Treating traumatic brain injury with psychedelics will get a closer study in a partnership between the World Boxing Council and Wesana Health.
Oregon’s Democratic Party Endorses Legalization of Psilocybin

Wake Receives First-Ever Approval for Psilocybin Microdose Study for Anxiety and Depression

In the first approval of its kind, Wake Network will study the effects of microdosing psilocybin on anxiety and depression.
How to Become a Psychedelic Facilitator

MDMA Study Finds More Than 60% Success Rate in PTSD Patients

New hope for PTSD sufferers as a study found a more than 60% success rate after taking MDMA in a clinical setting.
NIMH Addresses Critical Need for Fast-Acting Interventions for Severe Suicide Risk

NIMH Supports 8 Interventions for Severe Suicide Risk Including Ketamine, Esketamine

New treatment interventions approved by NIMH for use with high-suicide risks include two novel ketamine therapies.
MindMed’s Project Angie to Explore LSD for Pain Conditions

MindMed’s Project Angie to Explore LSD for Chronic Pain Treatment

Psychedelic life sciences company MindMed is exploring LSD as a means of pain management.
Promising Results from First Phase-3 Trial Investigating MDMA-Assisted Therapy for PTSD

Promising Results from First Phase-3 Trial Investigating MDMA-Assisted Therapy for PTSD

The first phase-3 trial of its kind investigating MDMA for PTSD is showing promising results.
Researchers Discover Therapeutic Potential of Non-Hallucinogenic Psychedelic

Researchers Discover Therapeutic Potential of Non-Hallucinogenic Psychedelic

Researchers have identified a psychedelic with no hallucinogenic characteristics using a new sensor.
Psilocybin Provides Long-Term Relief of Cancer-Related Anxiety, Depression: Study

Psilocybin Provides Long-Term Relief of Cancer-Related Anxiety, Depression: Study

A follow-up study has found long-term relief from anxiety and depression related to cancer diagnoses with use of psilocybin treatment.
Who Is Stanislav Grof? Meet the Psychedelic Pioneer and Father of Holotropic Breathwork

Who Is Stanislav Grof? Meet the Psychedelic Pioneer and Father of Holotropic Breathwork

,
Stanislav Grof is one of the earliest pioneers in psychedelics and holotropic breathwork.
Interactive Dreaming May Hold Similar Therapeutic Potential As Psychedelics

Interactive Dreaming May Hold Similar Therapeutic Potential As Psychedelics

Interactive or lucid dreaming may be as beneficial for mental health as lucid dreaming, new research finds.
Study Looking at Ibogaine for Opioid Addiction

New Study Will Look At Ibogaine Treatment for Opioid Addiction

A potent tool in the battle against opioid addiction, ibogaine treatment is the subject of a new study in the UK.
Psilocybin’s Relationship with Creativity a ‘Complicated’ Affair

Psilocybin’s Relationship with Creativity a ‘Complicated’ Affair, Study Finds

New research points to a connection between psilocybin mushrooms and creativity.
Psilocybin As Effective as Lexapro in Treating Depression: Study

Psilocybin As Effective as Lexapro in Treating Depression: Study

The first study of its kind compares psilocybin and the antidepressant Lexapro in treating depression. The results are promising.
Oregon’s Democratic Party Endorses Legalization of Psilocybin

Lower Doses of Psilocybin May Still Have Antidepressant Effects

Psilocybin taken at low doses could have powerful antidepressant effects, according to new research findings.
Can You Predict a 'Bad' Psychedelic Trip? And Can You Stop One Once It Starts?

Can You Predict a ‘Bad’ Psychedelic Trip? And Can You Stop One Once It Starts?

,
For all the benefits in taking psychedelic substance like psilocybin, there is the risk of having a bad trip.
Ketamine Therapy Shows Benefits in Treating Depression Related to Childhood Abuse

Ketamine Therapy Shows Benefits in Treating Depression Related to Childhood Abuse

,
Adults with depression who were abused or neglected as children responded better to intravenous ketamine therapy than depressed adults who were not mistreated, according to a poster presentation and discussion at the recent Anxiety and Depression…
The Company of Others: How Shared Psychedelic Experiences Influence Outcomes

The Company of Others: How Shared Psychedelic Experiences Influence Outcomes

,
Does taking psychedelics with others improve the experiences for all individuals? Researchers are looking at the benefits.
Yale to Study Psilocybin for Cluster Headaches

Yale to Study Psilocybin for Cluster Headaches

Psilocybin is showing relief as treatment for cluster headaches — a painful condition that affects more than 300,000 Americans a year.
Study Investigates Optimal Dosing for MDMA

Study Investigates Optimal Dosing for MDMA

Potential optimal MDMA dosages for therapeutic benefit and reduced adverse events were investigated in a new study published in the latest edition of the Journal of Psychopharmacology.
UCSF Launches Psychedelic Research Institute

UCSF Launches New Psychedelic Research Division

Psychedelic research is coming to the University of California in a new division to study MDMA.
Mass General to Study Psilocybin

Mass General to Study Psilocybin at New Psychedelic Research Center

Massachusetts General Hospital has launched a new center for psychedelic research. First up: the benefits of psilocybin.
Meditation and Psychedelics Have Similar Effects On Our Brains: Do We Need Both?

Meditation and Psychedelics Have Similar Effects On Our Brains: Do We Need Both?

,
The synergy between meditation and psychedelics has been long understood. Now, as research explores the benefits, do we need both?
Use of Psychedelic Shows Correlation With Better Overall Physical Health

Use of Psychedelics Show Correlation With Better Overall Physical Health

Do psychedelics improve health? A new study finds a correlation between user health and psychedelic experiences.
Low Doses of LSD Make Opioids Obsolete

Are Stereotypes Around Psychedelics Slowing Down Research?

Psychedelics come with history as party drugs. Are these stigmas slowing down progress?
Listening to Ecstasy: Can This Man Normalize MDMA for Seniors?

New Research Investigates Psilocybin as OCD Treatment

,
Researchers are looking at how psilocybin and other psychedelics may help with OCD (obsessive-compulsive disorder).
Psychedelic Use Linked to 20% Decreased Hypertension Risk, Study Finds

Psychedelic Use Linked to 20% Decreased Hypertension Risk, Study Finds

,
Psychedelic use may help to decrease the risk of hypertension, according to new research.
psychedelic mushrooms

New Study Finds Possible Mechanism for Psilocybin’s Anti-Depressive Effects

,
Scientists are closer to unraveling the mystery behind the psilocybin effects and its ability to offer anti-depressive benefits.
MAPS Founder Rick Doblin Talks MDMA Research for PTSD With Actress Mayim Bialik

MAPS Founder Rick Doblin Discusses MDMA Research for PTSD With Actress Mayim Bialik

,
Rick Doblin, the founder of MAPS, joined actress Mayim Bialik's podcast Breakdown to discuss MDMA and PTSD research.
Mushroom Conference

University of Wisconsin Opens Country’s First Master’s in Psychedelic Medicine

,
The University of Wisconsin is the first in the U.S. to offer a master's degree in development of psychedelic medicine.
Big Pharma Giant Merck Partners With Psychedelic Research Company NovaMind

Big Pharma Giant Merck Partners With Psychedelic Research Company Novamind

Pharmaceutical giant Merck is partnering with psychedelic research company Novamind to test a possible therapy for treatment-resistant depression.
Women Are More Likely to Use Psychedelics Than Men

Survey: Women Use Psychedelics More Often Than Men

,
A new survey finds women are more likely to self-treat with psychedelics than men, particularly for issues including depression and trauma.
These 24 Psychedelic Patents Are Paving the Way for Medicine 2.0

These 24 Psychedelic Patents Are Paving the Way for Medicine 2.0

,
Patents of psychedelic substances are paving the way for new research and treatment options for a variety of diseases.
Establishing the Ethical Imperative in Psychedelic Medicine

Researchers to Hone In On Most Therapeutic Doses of LSD

New research is looking into the optimal dose of LSD to further enhance the therapeutic benefits of the psychedelic.
Awakn Life Sciences Psychedelics

U.K. Psychedelic R&D Company Investigates MDMA, Ketamine for Addiction

Awakn Life Sciences is looking at psychedelics for addiction, namely MDMA and ketamine for alcohol use disorder.
Are the Subjective Effects of Psychedelics Necessary for Therapy?

Are the Subjective Effects of Psychedelics Necessary for Therapy?

Are the subjective effects - that is, the psychedelic trip itself - fundamental for therapeutic outcomes? New research explores.
Predicting Psychedelic Experience Outcomes Through Machine Learning

Algernon to Investigate DMT Microdose for Stroke Treatment

Algernon Pharmaceuticals is exploring the little-researched psychedelic substance DMT to see if it has potential in treating stroke patients.
Ketamine Therapy May Help Slow Progression of ALS

Ketamine Therapy May Help Slow Progression of ALS

New research is looking at ketamine therapy as a potential aid in slowing the deadly disease ALS, amyotrophic lateral sclerosis.
Beckley Psychtech Explores Psilocybin for Headache Treatment

Beckley Psytech Explores Psilocybin for Headache Treatment

,
A new study is looking at how psilocybin treatment may help to reduce debilitating short-lasting unilateral neuralgiform headache attacks.
Are 'Magic' Psilocybin Truffles the Fountain of Youth? New Study Looks at Anti-Aging Benefits

Are ‘Magic’ Psilocybin Truffles the Fountain of Youth? New Study Looks at Anti-Aging Benefits

New research is looking at psilocybin truffles as a potential anti-aging tool and aid in treating age-related psychiatric disorders.
Are Microdosing Benefits Real? A New Study Says It May All Be In Your Mind

Are Microdosing Benefits Real? A New Study Says It May All Be In Your Mind

MIcrodosing with psychedelics is gaining in popularity but new research says the placebo effect worked just as well.
First Of Its Kind $10 Million Psychedelic Research Center Comes to NYU

‘One-of-a-Kind’ $10 Million Psychedelic Research Center Comes to NYU

,
NYU will open a $10 million psychedelic research center to further its work in using psychedelic substances to treat mental health issues.
Study: 69% of Suicidal Patients Saw 'Significant' Improvement With Ketamine Therapy

Study: 69% of Suicidal Patients Saw ‘Significant’ Improvement With Ketamine Therapy

,
A new study links ketamine therapy to a significant reduction in thoughts of suicide for 69 percent of study participants.
New Research Compares Placebo and Psychedelic Microdosing Benefits

New Research Finds Significant Role of Expectations in Psychedelic Microdosing Benefits

Are the benefits of psychedelic microdosing all in our heads? A new study looks at the results compared to placebo. The results might shock you.
5meo-dmt

5-MeO-DMT: Can ‘Toad Juice’ Cure Depression?

, ,
Clinical trials will look at the benefits of 5-MEO DMT as a treatment for relief from a number of mental health issues including depression.
Ego Death and Psychedelics

Psychedelics Cause Ego Death: What You Need to Know

,
One aspect of the psychedelic experience is something called ego death. Can it help people with mental health issues?
Professor Michiel van Elk Psychedelics

Professor Michiel van Elk Awarded More Than $970,000 Grant to Study Psychedelics

Professor Michiel van Elk of the University of Leiden has been awarded a nearly $1 million to study psychedelics.
DMT Trials for Depression

First-Ever DMT Trials for Depression Approved in UK

The UK will begin the first DMT trials for depression after Imperial College received approval to test the psychedelic.
Psychedelics and Schizophrenia

Psychedelics and Schizophrenia: What’s the Link?

Can psychedelics help treat schizophrenia? LSD-25 sat on a shelf for five years before Swiss chemist Albert Hofmann decided to reopen research on this strange chemical. One day while at work at Sandoz Laboratories, he accidentally let LSD…
Psilocybin Four Times More Effective Than Antidepressants

Psilocybin Four Times More Effective Than Antidepressants, Study Finds

New research into the benefits of psilocybin point to significant improvements for those suffering with depression. The new study, published in the journal JAMA Psychiatry found the impact of psilocybin was “more than four…
Microdosing Results In Mental Health Benefits

Microdosing Results In Mental Health Benefits for 79% Of Users: Survey

A new study links microdosing psychedelics to improved mental health in the vast majority of subjects. Microdosing involves taking small amounts of substances such as LSD or psilocybin over an extended period of time. The low-level dosages…
Psychedelics and Neuroplasticity

Psychedelics and Neuroplasticity: Molding a New Way of Thinking

Can psychedelics improve neuroplasticity in the brain? Psychedelics are making a comeback. Over the past decade we have seen some unprecedented results in modern psychiatry. From psilocybin treating depression, to LSD treating alcoholism.…
Are You a Good Candidate for a Psychedelic Study

Are You a Good Candidate for a Psychedelic Study?

Could you be a candidate for taking part in a psychedelic study? What impact could it have on your mental health? Clinical studies are crucial to medical knowledge. They help researchers obtain valuable information about the safety…
Researchers Replicate Ketamine Effects

Researchers Replicate Ketamine Effects By Mimicking Brain Rhythms

Psychedelic-like states of consciousness may soon be achievable without the need for substances like ketamine, psilocybin, or MDMA. A new study, published in the journal Nature, suggests the ability to replicate these altered states of consciousness…
Psychedelics Are Helping Women Beat Breast Cancer

How Psychedelics Are Helping Women Beat Breast Cancer

In 2012, author Erica Rex had her first experience with psilocybin. She was three years into a breast cancer diagnosis. Could psychedelics hold the cure? Or at least, part of it? Research is beginning to point to a possible link. Rex volunteered…
Can Psychedelics Improve Your Sex Life

Can Psychedelics Improve Your Sex Life?

Research into psychedelics shows promise in treating a growing number of ailments including treatment-resistant depression, anxiety, PTSD, and post-operative pain. But it may do you some good in the bedroom, too, according to new scientific…
5-MeO-DMT Experiencing the Therapeutic God Molecule

5-MeO-DMT: Experiencing the Therapeutic God Molecule

Rafael was apprehensive at first. Sitting on a yoga mat facing the setting sun, he whispered to his wife, “I’m scared.” R5-MeO-DMT was a religious experience for Rafael. Recounting his second journey on the outlawed chemical on 5Hive,…
MindMed and NYU Team Up for $5 Million Psychedelic Research

MindMed and NYU Team Up for $5 Million Psychedelic Research and Training Program

Leading psychedelic biotech company, MindMed, has partnered with NYU’s Langone Health center. Together, they’ll work to develop the NYU Langone Health Psychedelic Medicine Research Training Program. It will lead to a psychedelic research…
Dr. Bronner’s Soap Donates $3 Million to Psychedelic Research and Advocacy

Dr. Bronner’s Soap Donates $3 Million to Psychedelic Research and Advocacy

Popular natural soap brand Dr. Bronner’s has launched a campaign to promote psychedelic therapy. ‍ Dubbed the “Heal Soul” campaign, Dr. Bronner’s hopes to draw attention to public education and advocacy work helping make psychedelic-assisted…
Johns Hopkins Center for Psychedelic & Consciousness Research Interview

Johns Hopkins Center for Psychedelic & Consciousness Research Interview

https://www.youtube.com/watch?v=oJiDDATv9uU&feature=emb_logo
Octopuses On MDMA Want to Snuggle

Octopuses On MDMA Want to Snuggle Just Like You

In the Netflix documentary My Octopus Teacher, filmmaker Craig Foster befriends an octopus in the Atlantic waters near his home. Over a year, he visits her nearly every day. Their bond, even though octopuses are solitary animals, becomes…
World’s Largest Registry on Psilocybin Use

Johns Hopkins to Build World’s Largest Registry on Psilocybin Use

The John Hopkins Center for Psychedelic and Consciousness Research (CPCR) will create the world’s largest registry on psilocybin use, the center announced last month. In a partnership with Unlimited Sciences, a psychedelic research nonprofit,…
Understanding Ayahuasca

Understanding Ayahuasca: Combining Clinical Insights With Personal Experience

The traditional Amazonian psychedelic concoction, Ayahuasca, has begun to receive widespread attention for its powerfully therapeutic benefits. As countless people from across the globe travel to destinations like Mexico and South America to…
Listening to Ecstasy: Can This Man Normalize MDMA for Seniors?

MAPS Brings In $30 Million to Fund MDMA Research

When the story is written about how psychedelic medicine emerged into the mainstream, there will be a chapter about August of 2020. Because the nonprofit Multidisciplinary Association for Psychedelic Studies (MAPS) just made history. Earlier…
Microdosing Psychedelics Recent Rediscovery

Microdosing Psychedelics: A Recent Rediscovery

James Fadiman begins by asking, “How many of you have never had any psychedelic experience?” He’s speaking to a Science And Nonduality (SAND) conference, a group that assembles scientists, philosophers, sages and mystics to explore…
Can a Compound in ‘Magic’ Mushrooms Cure Social Anxiety

Can a Compound in ‘Magic’ Mushrooms Cure Social Anxiety?

Social anxiety is a strange mix of fear, discomfort, and apprehension that many people experience in certain social settings. And in the U.S., many can be counted in the millions, as 7.1 percent of us experience it regularly and 12.1…

© 2021 Psychedelic Spotlight. All rights reserved. Owned and operated by Global Trac Solutions, Inc. a US publicly traded company (OTCPink: PSYC) | All Rights Reserved.